We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

A Phase I/II Study Safety and Efficacy Study of PCI of Gemcitabine and Chemotherapy in Patients With Cholangiocarcinomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01900158
Recruitment Status : Recruiting
First Posted : July 16, 2013
Last Update Posted : October 13, 2016
Information provided by (Responsible Party):
PCI Biotech AS

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : August 2019
  Study Completion Date : No date given